AI-Based Drug Discovery Company Atomwise Sets Its Sights on Inflammatory Disease Market

[ad_1] By Uduak Thomas Atomwise, which has historically used its AI platform to help drug developers identify compounds for their pipelines, is entering a new phase of its journey. This…